Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

NCT06376162 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory KMT2A-r Acute Leukemia
Relapsed/Refractory NUP98-r Acute Leukemia
Relapsed/Refractory NPM1-m Acute Leukemia

Interventions

DRUG: Ziftomenib
DRUG: Cytarabine
DRUG: Fludarabine

Sponsor

PedAL BCU, LLC

Collaborators

[object Object]